Moderna, Inc. earnings per share and revenue

MRNA earnings per share for the last quarter are 0.03 USD whereas the estimation was -1.80 USD which accounts for 101.66% surprise. Company revenue for the same period amounts to 1.86 B USD despite the estimated figure of 1.25 B USD. Estimated earnings per share for the next quarter are -2.67 USD, and revenue is expected to reach 1.08 B USD. Also watch annual changes over time to get a bigger picture of MRNA earnings per share and revenue dynamics.